Welcome to Markets Desk, your midday read on what's moving money and markets.
The biggest macro catalyst today is the ceasefire between Israel and Iran, and markets are responding decisively. Oil tumbled sharply as the halt in hostilities drained the geopolitical risk premium from crude, with European equities catching the tailwind — the DAX climbing higher on the combination of easing Middle East tensions and encouraging regional economic data out of Germany.
Shifting to dealmaking, GSK is reaching deep into its balance sheet, agreeing to acquire American oncology drugmaker Nuvalent for ten point six billion dollars. The move is a direct response to the patent cliff pressures squeezing major pharmaceutical revenues, and it signals that biotech acquisition appetite remains fierce as pipeline replenishment becomes existential for the industry's largest players.
And on the AI front, EY's global consulting AI leader Dan Diasio is pushing back against the dominant corporate playbook, arguing that companies chasing cost-cutting through artificial intelligence are capturing the smallest possible return on investment. His warning is pointed — leaders fixated on efficiency over growth are generating internal fear that actively suppresses the creative thinking AI is supposed to unlock.
That's the tape. Markets Desk, signing off the floor.
